747
Views
0
CrossRef citations to date
0
Altmetric
Editorial

What Does the Growing Prominence of Asia Mean for Pharmaceutical Safety Management?

Pages 1503-1506 | Published online: 13 Oct 2010

Bibliography

  • Thiers FA , SinskeyAJ, BerndtER. Trends in the globalization of clinical trials.Nature Rev. Drug Disc.7, 13–14 (2008).
  • Saint-Raymond A , SweeneyF. Clinical trials in developing countries: risk or opportunity?.Future Med. Chem.1(7), 1193–1195 (2009).
  • Chung W -H, Hung S-I, Hong H-S et al. A marker for Stevens-Johnson syndrome. Nature428, 486 (2004).
  • Lonjou C , ThomasL, BorotNet al. A marker for Stevens–Johnson syndrome…ethnicity matters. Pharmacogenomics J. 6(4), 265–268 (2006).
  • Kaniwa N , SaitoY, AiharaMet al. HLA-B locus in Japanese patients with antiepileptics and allopurinaol-related Stevens–Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9(11), 1617–1622 (2008).
  • Hata Y , UeharaH. A case where herbal medicine sho-seiryu-to induced interstitial pneumonitis.Nihon Kokyuki Gakkai Zasshi.43(1), 23–31 (2005).
  • Katayama H , HamadaH, YokoyamaAet al. A case of interstitial pneumonia caused by gosha-jinki-gan. Nippon Ronen Igakkai Zasshi. 41(6), 675–678 (2004).
  • Yang CS , Lin C-H, Chang SH, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am. J. Kidney Dis.35(2), 313–318 (2000).
  • Lai MN , WangSM, ChenPC, ChenYY, WangJD. Population-based case–control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.J. Natl Cancer Inst.102, 179–189 (2010).
  • Gautam CS , AdityaS. Irrational drug combinations: need to sensitize undergraduates.Indian J. Pharmacol.38, 169–170 (2006).
  • Gautam CS , SahaL. Fixed dose drug combinations (FDCs): rational or irrational: a view point.Br. J. Clin. Pharmacol.65(5), 795–796 (2007).
  • Newton PN , GreenMD, FernandezFM. Impact of poor-quality medicines in the ‘developing’ world.Trends Pharmacol. Sci.31, 99–101 (2010).
  • Report of the Food and Drug Administration. Combating Counterfeit Drugs.February18, 2004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.